Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
about
Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.Shikonin exerts antitumor activity in Burkitt's lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin.
P2860
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improving nelarabine efficacy ...... 3K/AKT/mTOR signaling pathway.
@en
Improving nelarabine efficacy ...... 3K/AKT/mTOR signaling pathway.
@nl
type
label
Improving nelarabine efficacy ...... 3K/AKT/mTOR signaling pathway.
@en
Improving nelarabine efficacy ...... 3K/AKT/mTOR signaling pathway.
@nl
prefLabel
Improving nelarabine efficacy ...... 3K/AKT/mTOR signaling pathway.
@en
Improving nelarabine efficacy ...... 3K/AKT/mTOR signaling pathway.
@nl
P2093
P2860
P50
P1476
Improving nelarabine efficacy ...... 3K/AKT/mTOR signaling pathway.
@en
P2093
Alberto Maria Martelli
Alessandra Cappellini
Alice Bertaina
Cecilia Evangelisti
Ester Orsini
Francesca Buontempo
Francesca Chiarini
Luca Maria Neri
P2860
P2888
P356
10.1186/S13045-016-0344-4
P577
2016-10-24T00:00:00Z
P6179
1000855132